Skip to content

Early Assisted Discharge for COPD Exacerbations With Telemonitoring.

Early Assisted Discharge With Generic Community Nursing and Pulmonary Physicians vs Telemonitoring at Home for Chronic Obstructive Pulmonary Disease Exacerbations

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01951261
Enrollment
116
Registered
2013-09-26
Start date
2012-03-31
Completion date
2018-12-31
Last updated
2020-10-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COPD Exacerbation

Keywords

Telemonitoring, COPD, Home care

Brief summary

To determine if an early assisted discharge program for acute exacerbations of COPD (AECOPD), with telemonitoring and telephone control, is equally effective and more efficient in terms of use of health care resources, that a home care provided by hospital respiratory nurses and pulmonologists.

Detailed description

This study seeks to improve the health of patients with AECOPD by home care after discharge from the Hospital using the technology of the information and the communication. The investigators want evaluate the efficiency, satisfaction (patients, keepers) and effectiveness of a program of early discharge with home care in patients with AECOPD with telemonitoring and telephone control, in relation to the traditional protocol of home care based on nurse and pulmonologist visits.

Interventions

PROCEDURETelemonitoring and telephone control

Early assisted discharge from hospital due to an exacerbation of chronic obstructive pulmonary disease, with telemonitoring of vitals signs (oxygen saturation, heart rate, respiratory rate, blood pressure, temperature and electrocardiogram)and telephone control dairy (morning, evening)by the pulmonologist.

Sponsors

Dr. López Viña
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* Patients admitted to the hospital with COPD exacerbation * No concomitant serious unstable diseases * Without fever in 48 hours * Aerosol treatment at the most every 6 hours * Treatment with glucocorticoid intravenous \< 40 mg twice a day * A thoracic radiograph without new disease * Subjective improvement of the patient * Familiar suitable environment

Exclusion criteria

* Neoplasias and other chronic diseases in terminal situation * Alcoholism * Intravenous medication * Disability to understand and take part in the program * Admitted to intensive care unit (ICU) or non invasive mechanical ventilation during the exacerbation * Unstability hemodynamic * To be an institutionalized patient.

Design outcomes

Primary

MeasureTime frameDescription
Time Until the First ExacerbationChange from stable to exacerbation the first time at 6 monthTime until the first exacerbation is the time that patient is stable before a new exacerbation and meaning a good control of the disease.

Secondary

MeasureTime frameDescription
State-Trait Anxiety Inventory (STAI)Participants will be followed for the duration of home care, an expected average of 7 daysThe structure of the scale resulting from the combination of item polarity dimensions and the original two factors (State and Trait Anxiety). Minimum value 0, maximum value 120. Lower score indicates higher anxiety.
Percentage of Participants With Medication Adherence Assessed Using Morinsky-Green-Levine TestParticipants will be followed for the duration of home care up 24 weeksConsists of a series of 4 contrasting questions with answers dichotomous yes / no, reflecting the patient's behavior regarding compliance with medication. They are intended to assess whether the patient adopts correct attitudes regarding treatment for his illness; it is assumed that if attitudes they are incorrect the patient is non-compliant.
SATISFAD 10Participants will be followed for the duration home care, an expected average of 7 daysInstrument that evaluates satisfaction with home care services in a self-administered. The score ranges from 0 to 30, with the worst value being zero and the best value being 30.
Number of Home VisitsParticipants will be followed for the duration of home care, an expected average of 7 days
COPD Assessment Test (CAT)Participants will be followed for the duration of home care and up to 4 weeksIt's a simple questionnaire for assessing and monitoring COPD. It quantifies chronic obstructive pulmonary disease (COPD) impact in routine practice to aid health status assessment. It's self-administered in 2 min. It consists of 8 items that measure aspects of cough, expectoration, chest tightness, dyspnea, domestic activities, self-confidence, sleep and energy. Each section is scored from 0 to 5 and therefore a maximum of 40 points can be obtained; a higher score indicates a greater negative impact of COPD. Significant clinical changes correspond to a variation of 2 points or more.
Monitoring ComplianceParticipants will be followed for the duration of home care, an expected average of 7 daysIt represents the compliance of the patients with respect to the sending of constants through the telemedicine monitor that should be (following the protocol) at least twice a day. The patient was considered compliant if he sent the constant at least 2 twice a day or non-compliant otherwise.

Countries

Spain

Participant flow

Participants by arm

ArmCount
Telemonitoring and Telephone Control
Early discharge from hospital with telemonitoring, telephone control and three nurse scheduled visits. Telemonitoring and telephone control: Early assisted discharge from hospital due to an exacerbation of chronic obstructive pulmonary disease, with telemonitoring of vitals signs (oxygen saturation, heart rate, respiratory rate, blood pressure, temperature and electrocardiogram)and telephone control dairy (morning, evening)by the pulmonologist.
58
Home Care
Early discharge from hospital with home care provided by hospital respiratory nurses and pulmonologists (dairy visits).
58
Total116

Withdrawals & dropouts

PeriodReasonFG000FG001
Overall StudyDeath10
Overall StudyLost to Follow-up43
Overall StudyProtocol Violation43

Baseline characteristics

CharacteristicTelemonitoring and Telephone ControlHome CareTotal
Age, Continuous68 years
STANDARD_DEVIATION 8
70 years
STANDARD_DEVIATION 8
69 years
STANDARD_DEVIATION 8
Body mass index (BMI) (Mean (Standard Deviation)27.1 Kg/m^2
STANDARD_DEVIATION 4
26.5 Kg/m^2
STANDARD_DEVIATION 4
26.8 Kg/m^2
STANDARD_DEVIATION 4
Race and Ethnicity Not Collected0 Participants
Sex: Female, Male
Female
13 Participants23 Participants36 Participants
Sex: Female, Male
Male
45 Participants35 Participants80 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
1 / 580 / 58
other
Total, other adverse events
0 / 580 / 58
serious
Total, serious adverse events
2 / 582 / 58

Outcome results

Primary

Time Until the First Exacerbation

Time until the first exacerbation is the time that patient is stable before a new exacerbation and meaning a good control of the disease.

Time frame: Change from stable to exacerbation the first time at 6 month

Population: The overall number of participants analyzed is not consistent with numbers provided in any of the rows in the participant flow module, because in the telemedicine group and the home care group, patients who readmission were not included, nor was the patient in whom the monitor did not work.

ArmMeasureValue (MEDIAN)
Telemonitoring and Telephone ControlTime Until the First Exacerbation47 days
Home CareTime Until the First Exacerbation48 days
p-value: <0.05Log Rank
Secondary

COPD Assessment Test (CAT)

It's a simple questionnaire for assessing and monitoring COPD. It quantifies chronic obstructive pulmonary disease (COPD) impact in routine practice to aid health status assessment. It's self-administered in 2 min. It consists of 8 items that measure aspects of cough, expectoration, chest tightness, dyspnea, domestic activities, self-confidence, sleep and energy. Each section is scored from 0 to 5 and therefore a maximum of 40 points can be obtained; a higher score indicates a greater negative impact of COPD. Significant clinical changes correspond to a variation of 2 points or more.

Time frame: Participants will be followed for the duration of home care and up to 4 weeks

Population: Not all study participants completed the test, so it does not correspond to the number of the flow chart.

ArmMeasureGroupValue (MEDIAN)
Telemonitoring and Telephone ControlCOPD Assessment Test (CAT)Initial10 score on a scale
Telemonitoring and Telephone ControlCOPD Assessment Test (CAT)At first month8 score on a scale
Home CareCOPD Assessment Test (CAT)Initial15 score on a scale
Home CareCOPD Assessment Test (CAT)At first month8 score on a scale
Secondary

Monitoring Compliance

It represents the compliance of the patients with respect to the sending of constants through the telemedicine monitor that should be (following the protocol) at least twice a day. The patient was considered compliant if he sent the constant at least 2 twice a day or non-compliant otherwise.

Time frame: Participants will be followed for the duration of home care, an expected average of 7 days

Population: In the home care group, patients did not send constants. Data from 55 patients were analyzed (2 readmissions and one patient in which the monitor failed were not included in the analysis)

ArmMeasureValue (MEAN)Dispersion
Telemonitoring and Telephone ControlMonitoring Compliance2.23 sending of constantStandard Deviation 1
Secondary

Number of Home Visits

Time frame: Participants will be followed for the duration of home care, an expected average of 7 days

ArmMeasureValue (MEAN)Dispersion
Telemonitoring and Telephone ControlNumber of Home Visits3.8 visitsStandard Deviation 1
Home CareNumber of Home Visits5.1 visitsStandard Deviation 2
Secondary

Percentage of Participants With Medication Adherence Assessed Using Morinsky-Green-Levine Test

Consists of a series of 4 contrasting questions with answers dichotomous yes / no, reflecting the patient's behavior regarding compliance with medication. They are intended to assess whether the patient adopts correct attitudes regarding treatment for his illness; it is assumed that if attitudes they are incorrect the patient is non-compliant.

Time frame: Participants will be followed for the duration of home care up 24 weeks

Population: Not all study participants completed the test, so it does not correspond to the number of the flow chart.

ArmMeasureGroupValue (NUMBER)
Telemonitoring and Telephone ControlPercentage of Participants With Medication Adherence Assessed Using Morinsky-Green-Levine TestInitial77 percentage of adherents
Telemonitoring and Telephone ControlPercentage of Participants With Medication Adherence Assessed Using Morinsky-Green-Levine TestAt 6 month86 percentage of adherents
Home CarePercentage of Participants With Medication Adherence Assessed Using Morinsky-Green-Levine TestInitial78 percentage of adherents
Home CarePercentage of Participants With Medication Adherence Assessed Using Morinsky-Green-Levine TestAt 6 month87 percentage of adherents
Secondary

SATISFAD 10

Instrument that evaluates satisfaction with home care services in a self-administered. The score ranges from 0 to 30, with the worst value being zero and the best value being 30.

Time frame: Participants will be followed for the duration home care, an expected average of 7 days

ArmMeasureValue (MEDIAN)
Telemonitoring and Telephone ControlSATISFAD 1030 score on a scale
Home CareSATISFAD 1030 score on a scale
Secondary

State-Trait Anxiety Inventory (STAI)

The structure of the scale resulting from the combination of item polarity dimensions and the original two factors (State and Trait Anxiety). Minimum value 0, maximum value 120. Lower score indicates higher anxiety.

Time frame: Participants will be followed for the duration of home care, an expected average of 7 days

Population: Not all study participants completed the test, so it does not correspond to the number of the flow chart.

ArmMeasureGroupValue (MEDIAN)
Telemonitoring and Telephone ControlState-Trait Anxiety Inventory (STAI)State15 score on a scale
Telemonitoring and Telephone ControlState-Trait Anxiety Inventory (STAI)Trait20 score on a scale
Home CareState-Trait Anxiety Inventory (STAI)State17 score on a scale
Home CareState-Trait Anxiety Inventory (STAI)Trait23 score on a scale

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026